HARLAN S ROBINS Insider Trading for January 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for HARLAN S ROBINS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of HARLAN S ROBINS for January 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 25 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 23,370 | 147,698 | 210,330 | |
| Jan 25 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 67.59 | 2,100 | 141,939 | 679 | 2.8 K to 679 (-75.57 %) |
| Jan 25 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 66.90 | 17,329 | 1,159,310 | 2,779 | 20.1 K to 2.8 K (-86.18 %) |
| Jan 25 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 66.06 | 3,941 | 260,342 | 20,108 | 24 K to 20.1 K (-16.39 %) |
| Jan 25 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 23,370 | 147,698 | 24,049 | 679 to 24 K (+3,441.83 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 50,000 | 316,000 | 133,700 | |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 50,000 | 316,000 | 183,700 | |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 68.20 | 4,661 | 317,880 | 679 | 5.3 K to 679 (-87.28 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 67.39 | 24,945 | 1,681,044 | 5,340 | 30.3 K to 5.3 K (-82.37 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 66.84 | 20,394 | 1,363,135 | 30,285 | 50.7 K to 30.3 K (-40.24 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 50,000 | 316,000 | 50,679 | 679 to 50.7 K (+7,363.77 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 70.75 | 2,100 | 148,575 | 679 | 2.8 K to 679 (-75.57 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 69.97 | 8,052 | 563,398 | 2,779 | 10.8 K to 2.8 K (-74.34 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 69.26 | 5,701 | 394,851 | 10,831 | 16.5 K to 10.8 K (-34.48 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 67.74 | 3,001 | 203,288 | 16,532 | 19.5 K to 16.5 K (-15.36 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 67.02 | 31,146 | 2,087,405 | 19,533 | 50.7 K to 19.5 K (-61.46 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 50,000 | 316,000 | 50,679 | 679 to 50.7 K (+7,363.77 %) |